PharmaCorp Completes Strategic Acquisitions Across Canada
PharmaCorp RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) has successfully finalized the acquisition of three community pharmacies, marking a significant milestone in its growth strategy.
Acquisitions in Western Canada
The corporation has acquired two pharmacies under the PharmaChoice Canada brand, located in Western Canada. These acquisitions were valued at $3,400,000, which will be adjusted according to standard procedures. Notably, 75% of this purchase price was settled with the corporation's cash reserves, while the remaining 25% was compensated through the issuance of common shares. The price for these shares corresponded to the volume-weighted average trading price observed on the TSX Venture Exchange, calculated over a period leading up to the acquisition closing.
Eastern Canada Expansion
PharmaCorp has also successfully concluded its acquisition of a pharmacy based in Eastern Canada, incurring a purchase price of $5,300,000. This amount too will be subject to customary adjustments and was covered through available cash and funds from the corporation’s credit line.
Strategic Growth and Community Commitment
Alan Simpson, Executive Chair of PharmaCorp, expressed his enthusiasm about these acquisitions. He highlighted that these strategic moves not only expand their footprint but also preserve the individual heritage of the acquired pharmacies while ensuring continuity of care for patients. This acquisition aligns closely with PharmaCorp’s growth strategy, demonstrating their commitment to future acquisitions in the pharmacy sector.
About PharmaCorp RX INC.
PharmaCorp currently operates seven pharmacies across Canada under the PharmaChoice Canada banner and aims to continue expanding by acquiring additional pharmacies both under the PharmaChoice brand and independently owned establishments. This strategic growth is designed to enhance their service offerings and operational footprint across the community pharmacy sector.
The company actively seeks discussions with pharmacy owners who are contemplating succession or sale of their businesses. For more details about their acquisition program, visit their official website or reach out to them directly.
Contact Information
For further inquiries, please contact:
Mr. Alan Simpson
Suite #203, 303 Wellman Lane, Saskatoon, SK S7T 0J1
Tel: (306) 536-3771
Frequently Asked Questions
What is the significance of PharmaCorp's acquisitions?
The acquisitions allow PharmaCorp to expand its community pharmacy presence, enhancing patient care capabilities and preserving local pharmacy legacies.
How much did PharmaCorp pay for the pharmacies?
PharmaCorp acquired the two pharmacies in Western Canada for $3,400,000 and the pharmacy in Eastern Canada for $5,300,000, subject to adjustments.
What is the future outlook for PharmaCorp?
PharmaCorp intends to remain active in acquisitions, continually expanding its network of community pharmacies across Canada.
Who is Alan Simpson?
Alan Simpson is the Executive Chair of PharmaCorp, leading the strategic initiatives and overseeing the corporation's growth and acquisition plans.
How can pharmacy owners discuss potential sales with PharmaCorp?
Pharmacy owners can contact PharmaCorp to confidentially discuss their options for succession or sale, ensuring a smooth transition.
